p53 is the most commonly mutated tumor suppressor in human cancers and plays critical roles in cell cycle arrest, apoptosis, differentiation and DNA repair. While recent studies also link p53 to aging, the exact roles of p53 in aging remains unclear because premature aging is only observed in some but not all mouse models that have increased p53 activities. In responses to various stresses, p53 protein levels are upregulated and its transcription activities activated. Posttranslational modifications of p53, including phosphorylation and acetylation, are thought to play important roles in regulating p53 responses to genotoxic and oncogenic stresses. To address the physiological roles of p53 posttranslational modifications in regulating its stability and activity, we have employed mouse knock-in technology to introduce missense mutations into the phosphorylation or acetylation sites of the endogenous p53 gene in embryonic stem (ES) cells and mice. These genetic studies have provided important and sometimes surprising insights into the complex regulation of p53. With these initial successes, I propose to continue to employ mouse genetics to investigate the roles of various phosphorylation and acetylation events in regulating p53 activity, and more importantly, in p53-dependent tumor suppression and aging in vivo.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA094254-09
Application #
8007365
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Pelroy, Richard
Project Start
2001-07-01
Project End
2012-12-31
Budget Start
2011-01-01
Budget End
2011-12-31
Support Year
9
Fiscal Year
2011
Total Cost
$333,795
Indirect Cost
Name
University of California San Diego
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Lu, X; Mazur, S J; Lin, T et al. (2014) The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. Oncogene 33:2655-64
Kim, J; Nakasaki, M; Todorova, D et al. (2014) p53 Induces skin aging by depleting Blimp1+ sebaceous gland cells. Cell Death Dis 5:e1141
Zhang, Zhen-Ning; Chung, Sun-Ku; Xu, Zheng et al. (2014) Oct4 maintains the pluripotency of human embryonic stem cells by inactivating p53 through Sirt1-mediated deacetylation. Stem Cells 32:157-65
Lu, X; Liu, D P; Xu, Y (2013) The gain of function of p53 cancer mutant in promoting mammary tumorigenesis. Oncogene 32:2900-6
Lake, Blue B; Fink, Jürgen; Klemetsaune, Liv et al. (2012) Context-dependent enhancement of induced pluripotent stem cell reprogramming by silencing Puma. Stem Cells 30:888-97
Liu, Dongping; Xu, Yang (2011) p53, oxidative stress, and aging. Antioxid Redox Signal 15:1669-78
Liu, Dongping; Ou, Linda; Clemenson Jr, Gregory D et al. (2010) Puma is required for p53-induced depletion of adult stem cells. Nat Cell Biol 12:993-8
Liu, D P; Song, H; Xu, Y (2010) A common gain of function of p53 cancer mutants in inducing genetic instability. Oncogene 29:949-56
Gaidarenko, O; Xu, Y (2009) Transcription activity is required for p53-dependent tumor suppression. Oncogene 28:4397-401
Jenkins, Lisa M Miller; Mazur, Sharlyn J; Rossi, Matteo et al. (2008) Quantitative proteomics analysis of the effects of ionizing radiation in wild type and p53 K317R knock-in mouse thymocytes. Mol Cell Proteomics 7:716-27

Showing the most recent 10 out of 18 publications